Received Oct 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (AFLURIA) | SEQIRUS, INC. | N/A | AX4605A | IM / LA |
S: Patient reports experiencing sudden onset of ringing in the ears (tinnitus) and dizziness approximately minutes after receiving the influenza vaccine. Patient stated it was hard to get up and move due to the dizziness. No chest pain, shortness of breath, rash, or swelling reported at the time of assessment. Patient stated she has a history of Vertigo and Hyper-acidity. O: Heart Rate: 83 bpm Blood Pressure: 160/80 mmHg Patient observed to be alert but visibly uncomfortable; also observed to have redness on the face. Ambulation limited due to dizziness. No visible signs of anaphylaxis (e.g., hives, swelling, respiratory distress). A: Presenting with tinnitus and dizziness, elevated BP noted. No immediate life- threatening signs, but symptoms concerning. P: Advised patient to seek immediate evaluation in the Emergency Department for further workup and monitoring. Vitals monitored during observation. Patient educated on signs and symptoms to report urgently (e.g., worsening dizziness, chest pain, difficulty breathing, loss of consciousness). Incident reported per vaccine adverse event protocol. Will follow up as needed pending ED evaluation.
None.
None.
None.
Aspirin.
None.